SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-015058
Filing Date
2021-07-30
Accepted
2021-07-30 16:24:14
Documents
2
Period of Report
2021-07-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asunovionamendment3xjuly23.htm 8-K 25760
2 EX-10.1 ex101_aquestive-sunovionam.htm EX-10.1 21749
  Complete submission text file 0001628280-21-015058.txt   48689
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 211132880
SIC: 2834 Pharmaceutical Preparations